Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Cardiovascular Disease Physician in New York, NY
NPI: 1447203401Primary Practice Location
MOUNT SINAI HOSPITAL
1184 5th Ave, New York, NY
Primary Employer
Cardio Vascular Institute of Mount Sinai
mountsinai.org
HQ Phone
Get M.D. Roxana's Phone Numberphone_androidMobile
Get M.D. Roxana's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
1991 - 2026
CT State Medical License
1990 - 2008
DC State Medical License
1997 - 2008
NY State Medical License
American Board of Internal Medicine
Cardiovascular Disease
Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
Fellowship • Cardiovascular Disease
1991 - 1995
University of Connecticut
Residency • Internal Medicine
1988 - 1991
Internship • Internal Medicine
1987 - 1988
St. George's University School of Medicine
Medical School
Until 1987
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 37 | 80 |
| 2 | 36415Insertion of needle into vein for collection of blood sample | 23 | 26 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 23 | 35 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 19 | 27 |
Authors: Jose Dizon
Journal: JACC Cardiovasc Interv
Modern war surgery: the experience of Bosnia. 2: The clinical experience.
Authors: Mehran R, Connelly P, Boucher P, Côté M
Publication Date: 1995-08
The bleeding risk score as a mortality predictor in patients with acute coronary syndrome.
Authors: Jose C. Nicolau, Humberto Graner Moreira, Luciano Moreira Baracioli, Carlos Vicente Serrano, Felipe G. Lima, Marcelo Franken, Roberto R. Giraldez, Fernando Ganem, Roberto Kalil Filho, José Antonio Franchini Ramires, Roxana Mehran
Publication Date: 2013-01
Lead Sponsor: Concept Medical Inc.
Intervention / Treatment: DEVICE: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family), DEVICE: Abluminus DES+ Sirolimus Eluting Stent System (SES)
Lead Sponsor: Boston Scientific Corporation
Intervention / Treatment: DEVICE: Percutaneous coronary intervention (Promus PREMIER)
Lead Sponsor: Regado Biosciences, Inc.
Collaborators: The Cleveland Clinic, Duke Clinical Research Institute, Icahn School of Medicine at Mount Sinai, Parexel, Canadian VIGOUR Centre
Intervention / Treatment: DRUG: Bivalirudin, DRUG: pegnivacogin/anivamersen
